CONTEXT THERAPEUTICS INC CNTX
COM · Common Stock · CUSIP 21077P108
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersPhiladelphia, PA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($465.0k this quarter). Holder counts are more reliable. Shares outstanding: 11.0m as of 2021-11-29, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $2.66.
Biggest buyers
| SABBY MANAGEMENT, LLC | New | +1.2m |
| AIGH Capital Management LLC | New | +762.7k |
| Altium Capital Management LLC | New | +493.5k |
| VANGUARD GROUP INC | New | +214.7k |
| Worth Venture Partners, LLC | New | +175.0k |
| Veritable, L.P. | New | +110.2k |
| RENAISSANCE TECHNOLOGIES LLC | New | +64.6k |
| Virtu Financial LLC | New | +53.5k |
| swisspartners Ltd. | New | +42.2k |
| QCM Cayman, Ltd. | New | +14.0k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Avidity Partners Management LP 13G · passive investor -1.2 pts · filed 2026-05-12 | 8.7% |
| Deep Track Capital, LP 13G · passive investor filed 2025-05-15 | 8.3% |
| Soleus Capital Master Fund, L.P. 13G · passive investor +2.4 pts · filed 2026-05-08 | 7.6% |
| BlackRock, Inc. 13G · institution new · filed 2026-07-27 | 6.7% |
Fell to 5% or below in the last year: MPM BioImpact LLC (1.4%, 2026-08-14), Blue Owl Capital Holdings LP (3.2%, 2026-08-12), Octagon Capital Advisors LP (3.3%, 2026-07-31), GREAT POINT PARTNERS LLC (2.4%, 2026-05-15)
Insider purchases and sales in Q4 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2020 | 0 | — | 0 | — | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 2 | $106.9k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2021-12-16 | Lehr Martin A. Chief Executive Officer, director · Martin Lehr 2000 Trust | Bought | $41.9k13.0k shares |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer, director | Bought | $50.0k10.0k shares |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer, director · Martin Lehr 2000 Trust | Bought | $50.0k10.0k shares |
| 2021-10-22 | Levit Alex C. Chief Legal Officer, Corp. Sec | Bought | $15.0k3.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2021
| Manager | Shares | Change |
|---|---|---|
| SABBY MANAGEMENT, LLC 0.84% of their portfolio | 1.2m $3.3m | New |
| AIGH Capital Management LLC 0.63% of their portfolio | 762.7k $2.0m | New |
| Altium Capital Management LLC 0.37% of their portfolio | 493.5k $1.3m | New |
| Empery Asset Management, LP 1.99% of their portfolio | 358.6k $954.0k | First filing |
| VANGUARD GROUP INC 0.00% of their portfolio | 214.7k $571.0k | New |
| Worth Venture Partners, LLC 0.23% of their portfolio | 175.0k $465.0k | New |
| Veritable, L.P. 0.00% of their portfolio | 110.2k $293.0k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 64.6k $172.0k | New |
| Virtu Financial LLC 0.01% of their portfolio | 53.5k $142.0k | New |
| swisspartners Ltd. 0.08% of their portfolio | 42.2k $114.0k | New |
| QCM Cayman, Ltd. 0.22% of their portfolio | 14.0k $37.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 11.5k $31.0k | New |
| HRT FINANCIAL LP 0.00% of their portfolio | 10.2k $27.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 5.0k $13.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.1k $6.0k | New |
| Amplius Wealth Advisors, LLC 0.00% of their portfolio | 600 $1.0k | First filing |
| Retirement Group, LLC 0.00% of their portfolio | 155 $0 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 100 $0 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 33 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |